Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
05/26/2006 | WO2005121369A3 Rna-containing microvesicles and methods therefor |
05/26/2006 | WO2005120557A3 Inhibition of macrophage-stimulating protein receptor (ron) |
05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
05/26/2006 | WO2005111238A3 Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
05/26/2006 | WO2005084306A3 Immunogenic compositions for chlamydia pneunomiae |
05/26/2006 | WO2005079533A3 Methods and compositions for mediating gene silencing |
05/26/2006 | WO2005072371A3 Branched polymeric sugars and nucleotides thereof |
05/26/2006 | WO2005014782A8 Double-stranded ribonucleic acid with increased effectiveness in an organism |
05/26/2006 | WO2004087878A3 Novel plant promoters for use in early seed development |
05/26/2006 | WO2004035765A3 Double-stranded rna structures and constructs, and methods for generating and using the same |
05/26/2006 | WO2003100007A3 Eta-1 gene and methods for use |
05/26/2006 | CA2590671A1 Antibodies against vascular endothelial growth factor receptor-1 |
05/26/2006 | CA2588072A1 Biomarkers for diagnosing schizophrenia and bipolar disorder |
05/26/2006 | CA2587854A1 Multicistronic sirna constructs to inhibit tumors |
05/26/2006 | CA2587719A1 Method of screening compound regulating the translation of specific mrna |
05/26/2006 | CA2587411A1 Sirna silencing of apolipoprotein b |
05/26/2006 | CA2586998A1 Structure-based compound design involving riboswitches |
05/26/2006 | CA2585178A1 High arachidonic acid producing strains of yarrowia lipolytica |
05/26/2006 | CA2582270A1 Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer's disease |
05/25/2006 | US20060112454 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
05/25/2006 | US20060112453 Dietary proteins with improved nutritional quality and reduced or negative allergenicity for human and animal consumption through genetic engineering |
05/25/2006 | US20060112451 Process for preparing ketocarotenoids in genetically modified organisms |
05/25/2006 | US20060112445 Novel regulatory regions |
05/25/2006 | US20060111564 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
05/25/2006 | US20060111563 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer; one pot deprotection; solution phase synthesis; solid phase synthesis |
05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
05/25/2006 | US20060111561 Novel proteins and nucleic acids encoded thereby |
05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
05/25/2006 | US20060111297 Blood factor domains |
05/25/2006 | US20060111287 Acetylated protein |
05/25/2006 | US20060110810 Methods and materials for the synthesis of organic products |
05/25/2006 | US20060110806 Docosahexaenoic acid producing strains of Yarrowia lipolytica |
05/25/2006 | US20060110802 DNA encoding novel 4-1BB ligand (4-1BB-L) polypeptides which are members of the tumor necrosis factor (TNF) receptor super-family; expression vectors and antibodies; use to stimulate proliferation of activated T-cells for immunotherapy |
05/25/2006 | US20060110801 Receptor for b. anthracis toxin |
05/25/2006 | US20060110800 Testis-specific receptor |
05/25/2006 | US20060110799 Mitogen-activated protein kinase kinase MEK6 and methods of use thereof |
05/25/2006 | US20060110797 Polypeptides having xyloglucanase activity and nucleic acids encoding same |
05/25/2006 | US20060110796 In vivo site-specific incorporation of N-acetyl-galactosamine amino acids in eubacteria |
05/25/2006 | US20060110793 Methods and compositions for increasing longevity and protein yield from a cell culture |
05/25/2006 | US20060110792 Potassium channels, nucleotide sequences encoding them, and methods of using same |
05/25/2006 | US20060110791 large-scale production of functionally active enzyme trypanothione reductase of Leishmania donovani; amplification, purification |
05/25/2006 | US20060110790 Expression system for large functional proteins |
05/25/2006 | US20060110789 Methods to mediate polyketide synthase module effectiveness |
05/25/2006 | US20060110772 Human and murine cytokine polypeptides |
05/25/2006 | US20060110771 Proteins capable of binding to female sex hormones and process for producing the same |
05/25/2006 | US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients |
05/25/2006 | US20060110761 Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof |
05/25/2006 | US20060110752 Analyzing the hybridization intensities, by using oligonucleotide probes, which is complementary to target nucleic acid sequence, using principal component analysis; genetic engineering ; rapid efficient method for analyzing polymorphic or biallelic markers |
05/25/2006 | US20060110749 Primer composition and method of using the same in the detection of Shigella sonnei |
05/25/2006 | US20060110742 Carrier tests for polycystic kidney disease in the cat |
05/25/2006 | US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
05/25/2006 | US20060110736 Hiv vaccine formulations |
05/25/2006 | US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis |
05/25/2006 | US20060110729 Method of dna testing for mycobacterium paratuberculosis strains |
05/25/2006 | US20060110727 Incorporating a base selected from the group consisting of 7-deazaguanosine, 2-aminopurine, 8-aza-7-deazaguanosine, 1H-purine, and hypoxanthine into the oligonuclotide of the oligonuleotide array |
05/25/2006 | US20060110440 Method and system for biasing cellular development |
05/25/2006 | US20060110400 Immunogenic conjugates |
05/25/2006 | US20060110397 Protein of given amino acid sequence; yeast-two-hybrid assay screening for agent which inhibits formation of heterodimer and gene expression; diagnosis and treatment of cancer |
05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
05/25/2006 | US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity |
05/25/2006 | US20060110385 Means and methods for diagnosing and treating affective disorders |
05/25/2006 | US20060110384 Novel proteins and use thereof |
05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
05/24/2006 | EP1658383A1 Improved bisulfite method employing size exclusion step |
05/24/2006 | EP1658364A2 Tubulin regulatory elements for use in plants |
05/24/2006 | EP1658311A2 Enhancing the circulating half-life of interleukin-2 proteins |
05/24/2006 | EP1658307A2 Methods for the early diagnosis of ovarian cancer |
05/24/2006 | EP1658303A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
05/24/2006 | EP1546392A4 Species specific dna detection |
05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
05/24/2006 | EP1005573B1 Dendritic nucleic acids exhibiting maximal self-assembly |
05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
05/24/2006 | EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
05/24/2006 | DE19882655B4 Verfahren zur Herstellung einer Sonde für die Nukleinsäurehybridisierung A process for producing a probe for nucleic acid hybridization |
05/24/2006 | CN1777447A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
05/24/2006 | CN1775803A Plant DREB transcription factor and its coding gene and use |
05/24/2006 | CN1775797A Boea clarkeane drought-resistant and salt-tolerance related gene and its coding protein and use |
05/24/2006 | CN1775796A Nucleic acid preparation |
05/24/2006 | CN1257282C Southern oligomycin biosynthetic gene cluster |
05/24/2006 | CN1257281C SARS virus resisting siRNA and its application |
05/24/2006 | CN1257280C Nucleotide peculiar to 0-antigen of 0170 type bacillus coli |
05/24/2006 | CN1257279C Nucleotide peculiar to 0-antigen of 0163 type bacillus coli |
05/24/2006 | CN1257278C Nucleotide peculiar to 0-antige of 0161 type bacillus coli |
05/24/2006 | CN1257277C Nucleotide peculiar to 0-antigen of 0155 type bacillus coli |
05/24/2006 | CN1257276C Nucleotide peculiar to 0-antigen of 043 type bacillus coli |
05/24/2006 | CN1257275C Nucleotide peculiar to 0-antigen of 0136 type bacillus coli |
05/24/2006 | CN1257274C Process for preparing plasmid in large scale with high yield |
05/24/2006 | CN1257180C Fast DNA extracting and purifying process with shell magnetic nanoscale particle of aminated silica |
05/24/2006 | CN1257179C Method for achieving human DNA using adhesive tape |
05/24/2006 | CN1257178C Nucleotide peculiar to 0-antigen of 021 type bacillus coli |
05/23/2006 | US7049491 Expression vector comprising DNA sequences coding modified insecticidal protein (CRY1AB) for biological pest control |
05/23/2006 | US7049489 Transgenic plant; transformation plant with nucleic acids; gene expression; shutter vectors; genetic engineering |
05/23/2006 | US7049432 Oligonucleotides having alkylphosphonate linkages and methods for their preparation |
05/23/2006 | US7049431 Antisense antibacterial cell division composition and method |
05/23/2006 | US7049430 Method of treating HIV infection and related secondary infections thereof |
05/23/2006 | US7049428 HCV variants |
05/23/2006 | US7049426 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
05/23/2006 | US7049425 Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor |